Published Medical Influenza Drug This technology uses two molecular compounds, ASN-D and LAS-T, that effectively bind to viral replication machinery inside infected cells and prevent the virus from spreading. By Brigham Young University
Published Medical Molecular Tweezers The molecule inhibits the principal cause, not symptom, of AD by disaggregating pre-existing Aβ40 and Aβ42 protein fibrils. The tweezer is non-toxic at concentrations up to 200 μM. By University of California, Los Angeles
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
